Background The coronavirus disease of 2019 (COVID‐19) is a global pandemic with over
266 million cases and 5 million deaths worldwide. Anti‐COVID‐19 vaccinations have had …

Introduction Reports of SARS-CoV-2 coronavirus (COVID-19) vaccine-related myocarditis,
particularly after mRNA vaccines, have raised concerns amongst the general public. This …

Background Post-marketing surveillance studies have raised concerns of increased
myocarditis rates following coronavirus disease-19 (Covid-19) mRNA vaccines. The present …

The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered
intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is …

COVID-19 mRNA vaccinations have recently been implicated in causing myocarditis.
Therefore, the primary aim of this systematic review and meta-analysis was to investigate the …

With the introduction of the coronavirus disease 2019 (COVID-19) mRNA vaccines, the
incidence of severe infection has significantly decreased. While the vaccines have been …

Background and aims Recent media reports of myocarditis after receiving COVID-19
vaccines, particularly the messenger RNA (mRNA) vaccines, are causing public concern …

Introduction The etiology of myocarditis often remains undetermined. A large variety of
infectious agents, systemic diseases, drugs, and toxins can cause the disease. We report the …

The mRNA vaccines against COVID-19 infection have been effective in reducing the number
of symptomatic cases worldwide. With widespread uptake, case series of vaccine-related …

Background Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines
(Pfizer-BioNTech and Moderna) has been increasingly reported. Incidence rates in the …